What drugs target Salmonella typhi Vi polysaccharide antigen?

3+ drugs target Salmonella typhi Vi polysaccharide antigen, including Typhim Vi (Sanofi Pasteur MSD), Vi-TT.

What drug classes act on Salmonella typhi Vi polysaccharide antigen?

Drug classes acting on Salmonella typhi Vi polysaccharide antigen include Inactivated bacterial vaccine, Typhoid conjugate vaccine, Conjugate vaccine.

Salmonella typhi Vi polysaccharide antigen — Drug Target

3 drugs 2 marketed 1 in Phase 3

All drugs that target Salmonella typhi Vi polysaccharide antigen — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Inactivated bacterial vaccine · Typhoid conjugate vaccine · Conjugate vaccine

Marketed (2)

Typhim Vi (Sanofi Pasteur MSD) · Universitaire Ziekenhuizen KU Leuven · Inactivated bacterial vaccine · Immunology / Infectious Disease
Typhim Vi is an inactivated typhoid vaccine that stimulates the immune system to produce antibodies against Salmonella typhi polysaccharide antigen.
Vi-TT · International Vaccine Institute · Typhoid conjugate vaccine · Immunology / Infectious Disease
Vi-TT is a typhoid conjugate vaccine that stimulates immune responses against Salmonella typhi by presenting the polysaccharide capsule antigen conjugated to a protein carrier.

Phase 3 pipeline (1)

Control Vaccine Typbar TCV® · International Vaccine Institute · Conjugate vaccine · Immunology / Infectious Disease
Typbar TCV is a conjugate vaccine that stimulates immune response against Salmonella typhi by presenting purified polysaccharide antigens conjugated to a carrier protein.